Plexium Alternatives & Competitors
12 companies similar to Plexium — Pushing the Boundaries of Targeted Protein Degradation to Improve Lives
Companies similar to Plexium
Biotheryx, Inc.
Degrading proteins. Saving lives. Building the leader in next-generation targeted protein...
San Diego, United States
Degron Therapeutics
Aims to become a global leader in the discovery and development of molecular glue degrader...
San Diego, United States
Differentiated Therapeutics Inc
What if you could predict molecules to make the cause of disease disappear?
San Diego, United States
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly select...
Boston, United States
Rival Readout
Competing with Plexium? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Atea Pharmaceuticals, Inc
Discovery & development of breakthrough therapies for COVID-19 patients and severe viral d...
Boston, United States
Adcentrx Therapeutics
Merging Chemistry and Biology to Benefit the Lives of Patients
San Diego, United States
DELIVER Therapeutics, Inc.
Applying high throughput screening technologies to deliver novel therapeutics
Houston, United States
Prazer Therapeutics
Pushing the Boundaries of Targeted Protein Degradation with #SPiDEM Platform
Seoul, Korea South
Ractigen Therapeutics
Turn on genes and turn off diseases
Suzhou, China
Orion Biotechnology
Unlocking the Therapeutic Potential of Metabolic GPCRs
Ottawa, Canada
Chordia Therapeutics Inc
We are passionate to deliver first in class cancer drugs to patients from Japan.
Fujisawa, Japan
Orionis Biosciences
Precision through target visibility and tunable design
Waltham, United States
About Plexium
Plexium, founded in 2018, is a pioneering biotechnology company based in the United States. The company is redefining the landscape of targeted protein degradation (TPD) with the ambitious mission of "Pushing the Boundaries of Targeted Protein Degradation to Improve Lives." Plexium's innovation primarily revolves aroun...
Rational design and discovery of protein degraders, Development of targeted protein degradation therapeutics, Clinical trials
Patients with high unmet medical needs, Healthcare institutions and systems, Pharmaceutical partners
Targeted Protein Degradation, Next-Generation Therapeutics, Monovalent Direct Degraders, Molecular Glues, Small Molecule Drugs, High Unmet Medical Needs, DELTA Discovery Platform, Ultra-High Throughput Screening, Cancer Therapies, Clinical-Stage Degraders, Druggable Target Expansion, Protein Degraders, PROTAC Alternatives, Therapeutic Innovation
B2B, Platform
Licensing, Performance Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Plexium: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Plexium on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
